GSKNEUTRAL

GSK FCF Yield Analysis

4.8%

Updated 300h ago·SEC filings & market data

Key Takeaway

The current FCF yield of 4.8% means that for every $100 of GSK’s market value, the company generates roughly $4.80 in free cash flow—cash left after operating costs and capital spending.

Sector Performance

58th percentile

GSK

4.8%

Sector Median

4.2%

Sector Avg

9.3%

Prior Period

4.6%(Aug 2026)

↑ Improving
📊

Deep Analysis

The current FCF yield of 4.8% means that for every $100 of GSK’s market value, the company generates roughly $4.80 in free cash flow—cash left after operating costs and capital spending.

This sits above the sector median of 4.1%, placing GSK in the 58th percentile among peers, so its cash generation is moderately better than typical. The trend is largely undefined: the year-over-year change is N/A, while the quarter-over-quarter change is +4.3%, and historical values show only 4.8% and 4.6% (most recent first), with no 8-quarter trend available. The level is slightly above median with a recent uptick, but the lack of a longer track record means this could shift quickly, offering modest yield with uncertain stability. For an investor, this combines a fair cash return with limited evidence of durability, so risk is neither low nor high. This metric supports the NEUTRAL verdict, as it shows no strong bullish or bearish signal beyond a mild positive quarter.

Frequently Asked Questions

What does the FCF Yield tell investors about GSK?

One of the purest measures of value. High FCF yield means the company generates a lot of cash relative to its price — favoured by value investors.

How is the FCF Yield calculated?

FCF Yield is calculated as: Free Cash Flow / Market Cap.

Who are GSK's closest peers by FCF Yield?

The closest peers by FCF Yield include: RARE (-18.7%), CG (-19.3%), RXRX (-20.3%), PLUG (-22.0%), NTLA (-22.5%).

The Formula

Free Cash Flow / Market Cap

Why It Matters

One of the purest measures of value. High FCF yield means the company generates a lot of cash relative to its price — favoured by value investors.

Advertisement

Master GSK's Valuation

Get the complete institutional research report covering all fundamental and technical metrics.

View full GSK research report

Free account — no credit card

GSK

4.8%

Sector Median

4.2%

Sector Avg

9.3%

How GSK's FCF Yield compares to sector peers.

Not financial advice. Research tool only. Data may be delayed.